$0.360
-0.015 (-4.05%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PMCB por análisis de gráficos similares
Alphio's PMCB stock price prediction model matches the current PharmaCyte Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.36 (+0.05%). The 1-week path is $0.39 (+7.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de PharmaCyte Biotech Inc?
PharmaCyte Biotech Inc (PMCB) appears to be a good buy right now due to its recent price performance and favorable technical indicators. The current price is $0.36, which is near the 52-week low of $0.30, indicating potential for upside as it has a 52-week high of $1.51. The stock has shown a 5-day change of +19.17%, suggesting a positive short-term momentum. Additionally, the forward P/E ratio is 7.02, indicating that the stock may be undervalued relative to its future earnings potential. However, a significant risk is the negative net income reported for the last quarter at -$4,873,411, which reflects ongoing financial challenges. Overall, the combination of a low entry price, potential for recovery, and positive short-term trends supports a buy recommendation.
PMCB cerró en $0.36 el Friday, tras bajar -4.05%
PharmaCyte Biotech Inc (PMCB) last closed at $0.36, losing -4.05%. These facts feed the 1-day and 1-week PMCB price prediction above.
Factores de la previsión
Los factores de la previsión de PharmaCyte Biotech Inc (PMCB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PMCB, ordenadas por similitud.
Análisis de estacionalidad de PMCB
Historically the probability of a positive November return for PMCB is 0.00%. January offers the highest probability of a positive month at 60.66%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PMCB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.07 | $1.07 | $1.11 | +197.77% |
| Dec 2026 | $0.86 | $0.95 | $0.97 | +162.59% |
En 2026, se proyecta que PharmaCyte Biotech Inc (PMCB) oscile entre $0.86 y $1.11.
Previsión mensual de PharmaCyte Biotech Inc para 2026
En Nov de 2026, se proyecta que PharmaCyte Biotech Inc promedie $1.07, con un mínimo de $1.07 y un máximo de $1.11.
En Dec de 2026, se proyecta que PharmaCyte Biotech Inc promedie $0.95, con un mínimo de $0.86 y un máximo de $0.97.
Artículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.